PRL3-Zumab in Patients With Advanced Solid Tumors

Clinical trial NCT07541001 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07541001
Sponsor: Intra-IMMUSG Pte Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2021-08-30
Primary completion: 2026-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.